Repurposing SARS-CoV-2 Ligands as Potential Therapeutics Against Human Metapneumovirus

Published: 6 May 2025| Version 1 | DOI: 10.17632/23dp444hgw.1
Contributor:
Pallavi M Shanthappa

Description

Repurposing SARS-CoV-2 Ligands as Potential Therapeutics Against Human Metapneumovirus: The data and code used in this research are provided.

Files

Institutions

  • Amrita Vishwa Vidyapeetham - Amritapuri Campus

Categories

Bioinformatics, Molecular Dynamics, Molecular Docking, Drug Repositioning

Licence